| ²é¿´: 243 | »Ø¸´: 1 | |||
ÉñÒ½Ñ©Ñ©Òø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖúÒ»Æ× ÒÑÓÐ1È˲ÎÓë
|
| 12.23,14.42,38.76,38.76,64.00,64.00,108.06,138.23,138.23,151.96,165.35 |
» ²ÂÄãϲ»¶
»¯¹¤Çóµ÷¼Á£¡
ÒѾÓÐ37È˻ظ´
²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ39È˻ظ´
279ѧ˶ʳƷרҵÇóµ÷¼ÁԺУ
ÒѾÓÐ19È˻ظ´
±¾¿ÆÉúÎïÐÅϢѧ£¬×Ü·Ö362 Çó07 08µ÷¼Á
ÒѾÓÐ7È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©×ö¹ý·Ö×ÓʵÑé
ÒѾÓÐ10È˻ظ´
»¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô
ÒѾÓÐ18È˻ظ´
Ò»Ö¾Ô¸0703»¯Ñ§ÕÐ61×îÖÕÅÅÃû62»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ33È˻ظ´
266µ÷¼Á
ÒѾÓÐ11È˻ظ´
271Çóµ÷¼Á
ÒѾÓÐ26È˻ظ´
Ò»Ö¾Ô¸085502£¬267·ÖÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´

ÓÐËù²»Îª
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 304 (´óѧÉú)
- ½ð±Ò: 9684.2
- É¢½ð: 16
- ºì»¨: 14
- Ìû×Ó: 1106
- ÔÚÏß: 814.3Сʱ
- ³æºÅ: 481441
- ×¢²á: 2007-12-17
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Éñҽѩѩ: ½ð±Ò+10 2015-02-02 18:17:25
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Éñҽѩѩ: ½ð±Ò+10 2015-02-02 18:17:25
|
1 . 2,3,20,21-dibenzo-4,7,10,13,16,19,25-heptaoxa-23,24-diazabicyclo[20.2.1]pentacosa-22,24-diene C24H28N2O7 ÏàËÆ¶È:54.5% Journal of Heterocyclic Chemistry 2010 47 555-557 Synthesis of crown compounds containing a 1,3,4-oxadiazole moiety: Microwave-assisted synthesis Moha Outirite, Mounim Lebrini, Michel Lagren¨¦e and Fouad Bentiss Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 2 . N-(4-Aminobutyl)(1-thyminyl)acetamide hydrochloride ÏàËÆ¶È:54.5% Magnetic Resonance in Chemistry 2003 41 169-176 Correlation between the reactivity and spectroscopic properties of N-substituted secondary thioamides. New intramolecular N¡¤¡¤¡¤H+¡¤¡¤¡¤N binding approach and proton complexes based on thioamide ligation Jarosław Spychała Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 3 . 1-(3-azido-3-deoxy-¦Â-D-arabinofuranosyl)thymine C10H13N5O5 ÏàËÆ¶È:54.5% European Journal of Organic Chemistry 2003 2003 2911-2918 Mycobacterium tuberculosis Thymidine Monophosphate Kinase Inhibitors: Biological Evaluation and Conformational Analysis of 2¡ä- and 3¡ä-Modified Thymidine Analogues Philippe Van Rompaey, Koen Nauwelaerts, Veerle Vanheusden, Jef Rozenski, H¨¦l¨¨ne Munier-Lehmann, Piet Herdewijn and Serge Van Calenbergh Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 4 . Orotic acid ethyl ester C7H8O4N2 ÏàËÆ¶È:54.5% Journal of Chinese Medicinal Materials 2008 31 1332-1334 Chemical Constituents of Solanum cathayanum XIE Ming-xia, ZHOU Yuan, ZOU Kun, CHENG Fan, LIU Rong Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 5 . N-(phenyl)-2-(3,5-dimethyl-4-iodo-1H-pyrazol-1-yl)-acetamide C13H14IN3O ÏàËÆ¶È:54.5% Indian Journal of Chemistry Section B 2014 53 733-739 Synthesis and biological screening of some novel 2-(1H-pyrazol-1-yl)-acetamides as lidocaine analogue Zalaru, Christina; Dumitrascu, Florea; Draghici, Constantin; Iovu, Mircea; Marinescu, Maria; Tarcomnicu, Isabela; Nitulescu, George Mihai Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 6 . ({5-methyl-2,6-dioxo-3-[(1R⁄,3R⁄,4R⁄ -3-(phosphono-methoxy)bicyclo[2.2.1]hept-1-yl]-3,6-dihydropyrimidin-1(2H)-yl}methyl)phosphonic acid C14H22N2O9P2 ÏàËÆ¶È:53.8% Bioorganic & Medicinal Chemistry 2014 22 2974-2983 From norbornane-based nucleotide analogs locked in South conformation to novel inhibitors of feline herpes virus Milan Dejmek, Hubert Hřebabecký, Michal Ѝ¢la, Martin Drač¨ªnský, Eliška Proch¨¢zkov¨¢, Pieter Leyssen, Johan Neyts, Jan Balzarini, Radim Nencka Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 7 . Compound 4 C13H26B10N2O5 ÏàËÆ¶È:50% Bioorganic & Medicinal Chemistry Letters 2002 12 2209-2212 Synthesis and biological evaluation of 3¡ä-Carboranyl thymidine analogues Junhua Yan, Charlotta Naeslund, Ashraf S. Al-Madhoun, Jianghai Wang, Weihua Ji, Guirec Y. Cosquer, Jayaseharan Johnsamuel, Stefan Sjöberg, Staffan Eriksson, Werner Tjarks Structure 13C NMR ̼Æ×Ä£Äâͼ |

2Â¥2015-01-21 22:10:09













»Ø¸´´ËÂ¥
-3-(phosphono-methoxy)bicyclo[2.2.1]hept-1-yl]-3,6-dihydropyrimidin-1(2H)-yl}methyl)phosphonic acid
5